Browsing Tag

ArkBio

Ark Biopharmaceutical Announces NMPA Acceptance and Priority Review of New Drug Application for…

Jason Junior Dec 9, 2022

SHANGHAI, China, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Shanghai Ark Biopharmaceutical Co., Ltd. (Ark Biopharmaceutical), a biopharma company dedicated to the discovery and development of drugs for pediatric and respiratory diseases, today…

Health

ArkBio Announces Completion of Patient Enrollment and Dosing in AIRFLO, a Phase III Registration…

Jason Junior Jan 25, 2022

SHANGHAI, China, Jan. 25, 2022 (GLOBE NEWSWIRE) -- On January 25, 2022, Shanghai Ark Biopharmaceutical Co., Ltd. (ArkBio) announced the completion of patient enrollment and dosing of ziresovir (AK0529) for the treatment of respiratory…